This study compares the interactive emotional/subjective effects of single doses of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and methylphenidate, a dopamine (DA) and norepinephrine (NE) transporter blocker, in healthy subjects. The primary goal is to determine the role of transporter mediated DA and NE release in the subjective response to MDMA in humans. The investigators hypothesize that methylphenidate will attenuate the subjective response to MDMA.
3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") is widely used by young people for its euphoric effects. MDMA releases serotonin (5-HT), dopamine (DA), and norepinephrine (NE). 5-HT release mainly contributes to the subjective effects of MDMA whereas NE release is involved in the cardiovascular and psychostimulant effects of MDMA. DA is also likely to be involved in the rewarding and reinforcing effects of drugs of abuse. However, the functional role of DA in the subjective effects of MDMA in humans is largely unclear. To determine the role of the DA transporter (DAT) in the response to MDMA in humans the investigators test the effects of the DA and NE transporter blocker methylphenidate on the subjective effects of MDMA. The investigators use a randomized double-blind placebo-controlled cross-over design with four experimental sessions. methylphenidate or placebo will be administered before MDMA or placebo to 16 healthy volunteers. Subjective and cardiovascular responses will be repeatedly assessed throughout the experiments and plasma samples are collected for pharmacokinetics. The primary hypothesis is that methylphenidate will significantly reduce the subjective effects of MDMA.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Enrollment
16
125 mg per os, single dose
1 hour before MDMA/placebo 60 mg methylphenidate per os, single dose
capsules identical to MDMA or methylphenidate
University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Subjective effect during 24 hours
subjective effects are repetitively assessed by standardized questionnaires.
Time frame: 24 hours
Blood pressure (mmHg)during 10 hours
Time frame: 10 hours
Neuroendocrine plasma levels during 10 hours
neuroendocrine parameters assessed: prolactin, cortisol, epinephrine, norepinephrine, oxytocin, pro-vasopressin, vasopressin, estrogen,and progesterone
Time frame: 10 hours
MDMA plasma levels during 24 hours
Time frame: 24 hours
Heart rate (beats/min)) during 10 hours
Time frame: 10
Emotional and cognitive empathy
emotional empathy is going to be assessed by the Multifaceted Empathy Test (MET). cognitive empathy is going to be assessed by the Facial Emotion Recognition Task and the MET.
Time frame: 5 hours
Prosocial behavior
Effects on prosociality will be assessed by the Social Value Orientation slide-measurement test.
Time frame: 5 hours
Genetic polymorphisms
Effects of genetic polymorphisms on the response to MDMA
Time frame: assessed after study completion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.